DIO Corporation (KOSDAQ:039840)
South Korea · Delayed Price · Currency is KRW 12,580
-360 (-2.78%)
Aug 12, 2026, 3:30 PM KST
DIO Corporation Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 169,595 | 164,078 | 119,650 | 155,818 | 131,306 | 150,037 |
Revenue Growth | 40.75% | 37.13% | -23.21% | 18.67% | -12.48% | 24.97% |
Gross Profit Gross Profit Growth | 112,510 | 109,387 | 73,048 | 112,703 | 89,222 | 107,552 |
Operating Income Operating Income Growth | 10,807 | 10,190 | -49,948 | 20,636 | -6,516 | 34,453 |
Net Income Net Income Growth | 8,150 | -1,363 | -41,320 | 3,311 | -20,458 | 28,255 |
Earnings Per Share EPS Growth | 596.75 | -100.00 | -2865.10 | 227.00 | -1380.09 | 1931.50 |
EPS Growth | - | - | - | - | - | 154.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Device Manufacturing Industry Medical Device Manufacturing Industry Growth | 148,527 | 143,311 | 107,794 | 138,040 | 113,436 | 135,833 |
Medical Device Sales Business Medical Device Sales Business Growth | 21,068 | 20,767 | 11,856 | 17,778 | 17,870 | 14,205 |
Total Total Growth | 169,595 | 164,078 | 119,650 | 155,818 | 131,306 | 150,037 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 44,110 | 48,018 | 54,857 | 11,665 | 22,232 | 34,884 |
Total Debt Total Debt Growth | 83,178 | 80,919 | 84,883 | 118,088 | 115,975 | 108,183 |
Net Cash (Debt) Net Cash Growth | -39,069 | -32,901 | -30,026 | -106,423 | -93,743 | -73,299 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2719.82 | -2409.06 | -2082.00 | -7310.35 | -6323.99 | -5010.73 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 14,228 | 16,587 | 14,656 | 5,439 | -1,026 | 6,253 |
Capital Expenditures CapEx Growth | -6,662 | -4,839 | -4,251 | -4,224 | -10,748 | -19,148 |
Free Cash Flow Free Cash Flow Growth | 7,566 | 11,748 | 10,405 | 1,215 | -11,774 | -12,896 |
Free Cash Flow Growth | -37.54% | 12.91% | 756.10% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.34% | 66.67% | 61.05% | 72.33% | 67.95% | 71.68% |
Operating Margin | 6.37% | 6.21% | -41.74% | 13.24% | -4.96% | 22.96% |
Pretax Margin | 2.61% | -4.02% | -42.17% | 6.68% | -16.05% | 22.54% |
Profit Margin | 4.81% | -0.83% | -34.53% | 2.13% | -15.58% | 18.83% |
FCF Margin | 4.46% | 7.16% | 8.70% | 0.78% | -8.97% | -8.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.08 | - | - | 98.25 | - | 19.57 |
Forward PE | 7.09 | 11.88 | 115.70 | 10.94 | 10.56 | 13.72 |
P/FCF Ratio | 21.90 | 19.25 | 21.46 | 267.70 | - | - |
PS Ratio | 0.98 | 1.38 | 1.87 | 2.09 | 2.22 | 3.69 |